Segment Information (Tables)
|
6 Months Ended |
Jun. 30, 2019 |
|---|
| Segment Reporting [Abstract] |
|
| Schedule of reportable business segment information |
Reportable business segment information is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
Asia |
$ |
35,162 |
|
|
$ |
35,767 |
|
|
$ |
68,758 |
|
|
$ |
63,530 |
|
Europe |
15,075 |
|
|
13,922 |
|
|
30,672 |
|
|
28,525 |
|
North America |
34,620 |
|
|
35,518 |
|
|
71,143 |
|
|
73,623 |
|
Latin America and Other |
5,867 |
|
|
6,059 |
|
|
11,423 |
|
|
12,930 |
|
Total net sales |
90,724 |
|
|
91,266 |
|
|
181,996 |
|
|
178,608 |
|
|
|
|
|
|
|
|
|
Contribution margin (1): |
|
|
|
|
|
|
|
|
|
|
|
Asia |
16,291 |
|
|
17,275 |
|
|
32,402 |
|
|
29,641 |
|
Europe |
4,822 |
|
|
4,648 |
|
|
9,827 |
|
|
9,709 |
|
North America |
12,026 |
|
|
11,180 |
|
|
25,418 |
|
|
24,592 |
|
Latin America and Other |
2,418 |
|
|
2,393 |
|
|
4,740 |
|
|
4,821 |
|
Total contribution margin |
35,557 |
|
|
35,496 |
|
|
72,387 |
|
|
68,763 |
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses (2) |
31,019 |
|
|
33,310 |
|
|
64,871 |
|
|
65,696 |
|
Operating income |
4,538 |
|
|
2,186 |
|
|
7,516 |
|
|
3,067 |
|
|
|
|
|
|
|
|
|
Other income (loss), net |
306 |
|
|
(1,807 |
) |
|
258 |
|
|
(1,067 |
) |
Income before provision for income taxes |
$ |
4,844 |
|
|
$ |
379 |
|
|
$ |
7,774 |
|
|
$ |
2,000 |
|
_________________________________________
(1) Contribution margin consists of net sales less cost of sales and volume incentives expense.
(2) Service fees in China totaled $2.3 million and $4.5 million for the three and six-month periods ended June 30, 2019, respectively, compared to $2.5 million and $4.0 million for the three and six-month periods ended June 30, 2018. These service fees are included in selling, general and administrative expenses.
Total assets per segment is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
June 30,
2019 |
|
December 31,
2018 |
Assets: |
|
|
|
|
|
Asia |
$ |
72,752 |
|
|
$ |
59,983 |
|
Europe |
17,683 |
|
|
16,414 |
|
North America |
117,182 |
|
|
109,091 |
|
Latin America and Other |
8,634 |
|
|
7,528 |
|
Total assets |
$ |
216,251 |
|
|
$ |
193,016 |
|
|
| Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, the United States and South Korea comprise 10 percent or more of consolidated net sales for the three and six-month periods ended June 30, 2019 and 2018, as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
United States |
$ |
32,194 |
|
|
$ |
32,914 |
|
|
$ |
66,155 |
|
|
$ |
68,140 |
|
South Korea |
18,923 |
|
|
19,608 |
|
|
37,451 |
|
|
34,192 |
|
Other |
39,607 |
|
|
38,744 |
|
|
78,390 |
|
|
76,276 |
|
|
$ |
90,724 |
|
|
$ |
91,266 |
|
|
$ |
181,996 |
|
|
$ |
178,608 |
|
|
| Schedule of revenue generated by each of the Company's product lines |
Net sales generated by each of our product lines is set forth below (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
Six Months Ended
June 30, |
|
2019 |
|
2018 |
|
2019 |
|
2018 |
Asia |
|
|
|
|
|
|
|
|
|
|
|
General health |
$ |
10,752 |
|
|
$ |
8,519 |
|
|
$ |
18,836 |
|
|
$ |
14,753 |
|
Immune |
199 |
|
|
133 |
|
|
357 |
|
|
434 |
|
Cardiovascular |
11,561 |
|
|
13,496 |
|
|
23,394 |
|
|
23,398 |
|
Digestive |
7,333 |
|
|
6,274 |
|
|
12,108 |
|
|
11,698 |
|
Personal care |
1,820 |
|
|
3,086 |
|
|
6,087 |
|
|
5,268 |
|
Weight management |
3,497 |
|
|
4,259 |
|
|
7,976 |
|
|
7,979 |
|
|
35,162 |
|
|
35,767 |
|
|
68,758 |
|
|
63,530 |
|
Europe |
|
|
|
|
|
|
|
|
|
|
|
General health |
$ |
5,372 |
|
|
$ |
5,424 |
|
|
$ |
11,120 |
|
|
$ |
10,928 |
|
Immune |
1,090 |
|
|
832 |
|
|
2,363 |
|
|
1,776 |
|
Cardiovascular |
2,766 |
|
|
2,806 |
|
|
5,617 |
|
|
5,863 |
|
Digestive |
3,550 |
|
|
3,134 |
|
|
7,181 |
|
|
6,362 |
|
Personal care |
1,661 |
|
|
1,048 |
|
|
3,160 |
|
|
2,211 |
|
Weight management |
636 |
|
|
678 |
|
|
1,231 |
|
|
1,385 |
|
|
15,075 |
|
|
13,922 |
|
|
30,672 |
|
|
28,525 |
|
North America |
|
|
|
|
|
|
|
|
|
|
|
General health |
$ |
14,934 |
|
|
$ |
15,731 |
|
|
$ |
30,682 |
|
|
$ |
31,830 |
|
Immune |
3,340 |
|
|
3,344 |
|
|
7,558 |
|
|
8,279 |
|
Cardiovascular |
4,935 |
|
|
4,870 |
|
|
10,011 |
|
|
9,671 |
|
Digestive |
8,523 |
|
|
8,521 |
|
|
17,244 |
|
|
17,497 |
|
Personal care |
1,598 |
|
|
1,268 |
|
|
2,946 |
|
|
2,843 |
|
Weight management |
1,290 |
|
|
1,784 |
|
|
2,702 |
|
|
3,503 |
|
|
34,620 |
|
|
35,518 |
|
|
71,143 |
|
|
73,623 |
|
Latin America and Other |
|
|
|
|
|
|
|
|
|
|
|
General health |
$ |
1,783 |
|
|
$ |
1,794 |
|
|
$ |
3,395 |
|
|
$ |
3,878 |
|
Immune |
602 |
|
|
567 |
|
|
1,210 |
|
|
1,267 |
|
Cardiovascular |
361 |
|
|
288 |
|
|
700 |
|
|
766 |
|
Digestive |
2,645 |
|
|
2,931 |
|
|
5,181 |
|
|
5,883 |
|
Personal care |
260 |
|
|
302 |
|
|
517 |
|
|
613 |
|
Weight management |
216 |
|
|
177 |
|
|
420 |
|
|
523 |
|
|
5,867 |
|
|
6,059 |
|
|
11,423 |
|
|
12,930 |
|
|
$ |
90,724 |
|
|
$ |
91,266 |
|
|
$ |
181,996 |
|
|
$ |
178,608 |
|
|
| Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprised 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
June 30,
2019 |
|
December 31,
2018 |
Property, plant and equipment: |
|
|
|
|
|
United States |
$ |
57,608 |
|
|
$ |
60,606 |
|
Other |
4,303 |
|
|
3,455 |
|
Total property, plant and equipment |
$ |
61,911 |
|
|
$ |
64,061 |
|
|